Shares in Esperion Therapeutics lost more than half of their value after it disclosed a dispute with Daiichi Sankyo on a $300 million milestone payment relating to cholesterol drug Nexletol.

On Tuesday, Daiichi Sankyo Company, Limited (4568:JP) (OTC: DSNKY) shares maintained a positive outlook as TD Cowen sustained its Buy rating and JPY46.00 price target on the company's stock.

(Bloomberg) -- Shares of AstraZeneca Plc and Daiichi Sankyo Co. tumbled after the pair’s lung cancer drug showed mixed results in a late-stage trial. Astra dropped as much as 5.4% in early London ...

WILMINGTON, Del. - AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo's datopotamab deruxtecan (Dato-DXd) has shown a trend toward improving overall survival (OS) compared with chemotherapy in a Phase ...

AstraZeneca and Roche are co-developing and commercializing a companion diagnostic for the biomarker. AstraZeneca and Daiichi Sankyo unveiled a novel AI-powered biomarker on Sunday which can predict ...

Patritumab deruxtecan is under clinical development by Daiichi Sankyo and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase II drugs for Endometrial Cancer have a 22% phase ...

(RTTNews) - Merck & Co., Inc. (MRK) and Daiichi Sankyo (DSKYF.PK) announced that an interim analysis of the dose-optimization phase of the ongoing IDeate-Lung01 Phase 2 trial shows ifinatamab ...

Data at WCLC and ESMO showcasing Daiichi Sankyo’s progress towards its goal of creating new standards of care for patients with cancer will include six late-breaking presentations, including two ...

Daiichi Sankyo has identified inequalities in cardiovascular disease treatment and outcomes, finding that women in Europe are less likely than men to receive lipid-lowering therapies and achieve ...

A former employee of a pharmaceutical company who allegedly poisoned his wife to death with methanol in 2022 pleaded not guilty Monday, saying everything he’s been accused of is wrong.

NHK has learned that workers failed to check the alignment of pipes to be used for the test retrieval of nuclear fuel debris from a reactor at the damaged Fukushima Daiichi nuclear plant.

2,3 Patient comorbidities and frailty may unnecessarily affect CVD management. 4,5,6 Daiichi Sankyo remains committed to its promise to continue expanding medical knowledge to support better CV ...